Vascular

MicroVention, Inc., has announced that enrollment has begun in the Hydrogel Endovascular Aneurysm Treatment (HEAT) clinical trial, a prospective randomised study of the use of coiling technologies to treat intracranial aneurysms.

W. L. Gore & Associates, Inc. has received CE mark for the 23 mm and 27 mm diameter sizes of the contralateral leg component of the Gore® Excluder® AAA Endoprosthesis for treatment of abdominal aortic aneurysms(AAA). The company says its new diameter devices provide physicians with the ability to repair AAAs in a wider range of anatomies eligible for minimally invasive endovascular AAA repair.

Teleflex Incorporated has announced its ArrowADVANTAGE5 pressure-injectable peripherally inserted central catheter has received FDA 510(k) clearance for central venous pressure monitoring indication.

Flexible Stent Solutions has been granted CE mark for an extended range of its Flexstent peripheral vascular stents. The new line, called Flextent Iliac, does pretty much what it says on the tin, extending the company’s offering to cover more vessels.

A new technique involving retrograde endovascular approach to occluded peripheral arteries shows promise, but hasn’t yet been formally studied. Cook Medical is supporting a multicentre effort to build an evidence base for what could be a promising solution to the major healthcare problems resulting from peripheral artery disease.

University of Pittsburgh’s cell-free, biodegradable artery graft results in a regenerated artery in 90 days, leaving behind no trace of synthetic graft materials in the body.

Teleflex Incorporated has acquired Semprus BioSciences who’s core Semprus Sustain™ Technology for coating devices is designed to reduce the attachment of platelets and blood proteins at the device surface.

View From The Med is our weekly reflection on the events of the past seven days. This week has been a busy one as usual with a few gems. Enjoy.

Trireme hasn’t really explained why its PTA balloon catheter is called chocolate, but clinicians won’t care if FDA’s approval of further sizes means they can use it for more peripheral vascular indications.

Maquet is trumpeting its new generation of antibiotic/silver treated vascular grafts which it claims are effective against MRSA. The graft, branded Intergard Synergy, has gained CE mark status and is ready for launch.

St. Jude Medical, Inc. has received FDA clearance and will immediately launch the Amplatzer™ Vascular Plug 4 for use in transcatheter embolisation procedures within the peripheral vasculature.

J&J’s Cordis division is worried that one lot of its Fire Star Rx Balloon Catheters runs the risk of deflating too slowly or worse, not at all. The recall is limited to certain Far Eastern countries.

A new market research report has been published which claims bare metal stents will account for $1.86Bn sales by 2015. And if you buy it you get a free hour with an analyst.

Medtronic, Inc. has synchronised the U.S. launch of the recently FDA cleared Endurant® II AAA Stent Graft System with the Society for Vascular Surgery’s Vascular Annual Meeting being held right now. The company claims its new iteration enhances access and ease of use compared with the first generation product.

Hansen Medical, Inc. has announced that it has received FDA 510(k) clearance for its Magellan™ Robotic System, opening the door for transformation of vascular interventions.

Biotronik’s press department was in overdrive at EuroPCR last week, announcing that twelve-month results from the BIOSOLVE-I study with the DRug Eluting Absorbable Metal Scaffold (DREAMS) demonstrate safety and confirm vessel vasomotion.